Andreessen Horowitz August 13, 2024
Bowen Liu, PhD, investing partner, and Surya Ganguli, PhD, venture partner, join Vijay Pande, PhD, general partner of a16z Bio + Health.
Together, they detail different methods through which AI could assist drug development, the opportunity for AI to flag new targets and compounds for scientists to investigate, and the science fiction-sounding notion of developing a foundation model that untangles biology.
This is an in-depth conversation from three AI experts and biologists, so we’re publishing the transcript below.
Transcript lightly edited and may contain occasional errors.
Olivia Webb: Hello and welcome to Raising Health, where we explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. I’m Olivia,
Kris Tatiossian: and I’m Kris....
Today's Sponsors
Today's Sponsor